This report serves as a critical cornerstone for the latest evidence-based clinical insights related to the rising prevalence and significant health impact of metabolic dysfunction-associated steatohepatitis, or MASH, said Maryam Tabatabai, PharmD, associate vice president of clinical information
Providers must submit detailed narratives explaining why GLP-1 therapy suits individual patient circumstances rather than relying on standard diagnosis codes alone
Nakamaru Y, Akahoshi F, Iijima H, Hisanaga N, Kume T
et al., Cell, 2022 2274-C ADIPOSE TISSUE NAT10 IS ESSENTIAL FOR THE DEVELOPMENT OF NAFLD Qianren Zhang 1 , Rui Xue 1 , Ren Tianyi 1 and Jiangao Fan 2 , (1)Department of Gastroenterology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, (2)Department of Gastroenterology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China Background: Adipose tissue dysfunction has been closely linked with nonalcoholic fatty liver disease (NAFLD), but the underlying mechanisms remain to be elucidated
Krasemann et al., 2017), and monocyte-derived TREM2-expressing disease inflammatory macrophages (DIM